Member Exclusive

Cell therapy weekly: Yescarta “is not recommended” for NHS availability

This week: Kymriah receives European Commission approval and safety of MSC administration in ALS patients confirmed

Go to the profile of RegMedNet
Aug 30, 2018
0
0

Please sign in or register for FREE

No comments yet.